Flow cytometry market
                     Flow cytometry market analysis  size, share, outlook, and opportunity analysis, 2020 - 2027 
The requisite for disease diagnosis and advancements in technology of flow cytometry, in turn are 
expected to fuel growth of the flow cytometry market over the forecast period. Manufacturers are 
focusing on technological innovations in flow cytometry to tap into the emerging markets. For instance, 
in August 2017, Beckman Coulter Life Sciences received 510(k) clearance from the U.S. Food and Drug 
Administration (FDA) for its latest clinical flow cytometry product, the Navios EX flow cytometer, to be 
used in the clinical laboratories in the U.S. Furthermore, Sysmex America, Inc. in October 2017, launched 
CyFlow Antibodies, a comprehensive portfolio of Analyte Specific Reagent (ASR) antibodies for usage in 
flow cytometry applications, as a part of its initiative to offer cutting-edge clinical laboratory products. 
Moreover, major players are focusing on the product launches for enhancing their product portfolio and 
to strengthen their market positions. For instance, in June 2019, Becton, Dickinson and Company (US) 
launched its FlowJo software version 10.6 for flow cytometry data analysis that can be further 
integrated with BD FACSDiva for enhancing its capabilities to analyze multiple flow cytometry runs and 
compare data in a single view. 
Get the sample link:-  
https://www.coherentmarketinsights.com/insight/request-sample/1152  
The global flow cytometry market was valued at US$ 3,886.1 million in 2018 and is expected to exhibit a 
CAGR of 10.2% over the forecast period (2019-2027). 
Major market players are focused on product launches in the market, which is expected to boost the 
market growth over the forecast period. For instance, in March 2017, Cytek Biosciences Inc., a 
manufacturer and supplier of flow cytometry products and services launched its DxP Athena flow 
cytometry system. The system is compact, powerful, easy-to-use cell analyzer that are typically only 
found in conventional instruments that come with a much higher price tag. The DxP Athena makes the 
benefits of flow cytometry which are more readily available to larger number of researchers by its 
compact size. 
Furthermore, in April 2018, Merck KGaA launched its new Cell Stream benchtop flow cytometry system, 
a compressed, customizable flow cytometer that uses a camera for detection of the specimen. It is a 
unique optics system and this design offers researchers with unparalleled sensitivity and flexibility, when 
analyzing cells and submicron particles. This launch helped the company to expand its product line in 
flow cytometers. 
 
North America is expected to hold a dominant position in the market, owing to large healthcare industry 
in the region. To retain its position in the market, key players are focused on launching new products in 
the region. For instance, in September 2017, Beckman Coulter, Inc. (U.S.), launched their first flow 
cytometry CytoFLEX LX for the cancer researchers, which has the visible spectrum in a standard 
configuration. This launch helped in expanding its business in flow cytometry. 
Get PDF link:- 
 https://www.coherentmarketinsights.com/insight/request-pdf/1152    
Moreover, Europe is expected to hold the second largest market share over the forecast period, owing 
to product launches in the European market. For instance, In September2017, Miltenyi Biotec GmbH 
(Germany) launched a fully automated high-throughput flow cytometry MACSQuant X which handles 
384-well plates in less than 60 minutes giving users fast, reliable, and reproducible results. Launching 
these products has expanded the flow cytometry product line of company. 
Moreover, Asia Pacific is expected to witness significant growth in the market, owing to rising cases of 
cancers in the region.  For instance, according to the World Health Organization (WHO), in 2018, there 
were 3.9 million number of prevalent cases for cancers and 2.0 million number of new cancer cases are 
reported each year  in the Asia Pacific. 
Key Players 
Major players operating in the global flow cytometry market include Becton Dickinson and Company, 
General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, 
Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc., and 
Danaher Corporation. 
Get the main link:- 
 https://www.coherentmarketinsights.com/market-insight/flow-cytometry-market-1152  
About Coherent Market Insights: 
 
Coherent Market Insights is a prominent market research and consulting firm offering action-ready 
syndicated research reports, custom market analysis, consulting services, and competitive analysis 
through various recommendations related to emerging market trends, technologies, and potential 
absolute dollar opportunity. 
 
ContactUs: 
Mr.Shah 
Coherent Market ,Insights 
10014thAve, 
#3200 
Seattle,WA98154 
Tel:+1-206-701-6702